The Genetics Podcast
Un pódcast de Sano Genetics - Jueves
196 Episodo
-
EP 96: CEO of Montai Health, Margo Georgiadis, talks the intersection of nature and AI
Publicado: 13/4/2023 -
EP 95: Resharing Eric Topol on how Machine Learning & AI can Contribute to the Future of Healthcare
Publicado: 31/3/2023 -
EP 94: Alnylam’s Dr Paul Nioi on how genetics is used in drug target discovery
Publicado: 16/3/2023 -
EP 93: International Perspectives on Access to Genetic Testing in ALS
Publicado: 24/1/2023 -
EP 92: Four Predictions for 2023
Publicado: 5/1/2023 -
EP 91: 2022 Genetics Round-up with Dr Veera Rajagopal
Publicado: 24/12/2022 -
EP 90: Patient-centric drug development in ALS with Ronald van der Geest, Chief Development Officer of Treeway
Publicado: 8/12/2022 -
EP 89: Baroness Nicola Blackwood on the UK's leading role in delivering 'genomic healthcare for everyone'
Publicado: 24/11/2022 -
EP 88: Precision oncology: how Next Generation Sequencing (NGS) is powering care today and the treatments of the future with Christine Ward (Takeda) and Geoff Oxnard (Foundation Medicine)
Publicado: 10/11/2022 -
EP 87: Representation Matters: Why equitable access and community engagement are critical in genetic research
Publicado: 27/10/2022 -
EP 86: Heidi Rehm PhD, Chief Genomics Officer at Massachusetts General Hospital on curating and collaborating genomic datasets to guide the future of diagnostic and clinical research
Publicado: 13/10/2022 -
EP 85: Dr Jessica Kissinger on large-scale parasite genomics and the power of multi-omic data
Publicado: 29/9/2022 -
EP 84: Mark Kotter, CEO, and Founder of bit.bio, on creating every cell type and kickstarting a cell therapy revolution
Publicado: 1/9/2022 -
EP 83: Daphne Koller, Founder & CEO of Insitro - Integrating machine learning and biology at scale to reimagine drug discovery
Publicado: 11/8/2022 -
EP 82: Lessons from the world's largest genomic datasets with Daniel MacArthur, Director of the Centre for Population Genomics.
Publicado: 13/7/2022 -
EP 81: Cracking the druggable genome with Dietrich Stephan, Founder and CEO of NeuBase Therapeutics
Publicado: 29/6/2022 -
EP 80: Rare disease genomics and the 'near-coding' genome with Nicky Whiffin, Group Leader at the Wellcome Centre for Human Genetics
Publicado: 15/6/2022 -
EP 79: The Unknown Causes of Kidney Disease Project with Michael Spigler, Vice President of Patient Support and Education at American Kidney Fund
Publicado: 1/6/2022 -
EP 78: From datasets to front-line healthcare; polygenic risk scores and genomic prediction with Prof Sir Peter Donnelly, CEO of Genomics PLC
Publicado: 18/5/2022 -
EP 77: The journey to novel gene therapies for hearing loss and balance disorders with Laurence Reid, CEO at Decibel Therapeutics
Publicado: 4/5/2022
Exploring all things genetics. Dr Patrick Short, University of Cambridge alumnus and CEO of Sano Genetics, analyses the science, interviews the experts, and discusses the latest findings and breakthroughs in genetic research. To find out more about Sano Genetics and its mission to accelerate the future of precision medicine visit: www.sanogenetics.com